Introduction Semaglutide, A groundbreaking medication, has emerged as a transformative solution for managing type 2 diabetes, obesity, and overall metabolic health. A part of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone called glucagon-like peptide-1 (GLP-1), which regulates blood sugar, promotes insulin secretion, and suppresses appetite. Its dual https://online-cancer-consultatio37047.ivasdesign.com/53318759/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health